
GC71089
WU-04
Also known as N-[(1S,2R)-2-[4-bromo-2-(methylcarbamoyl)-6-nitroanilino]cyclohexyl]isoquinoline-4-carboxamide
WU-04 is a non-covalent inhibitor of SARS-CoV-2, targeting the 3CLpro protein
ChemicalCAS2921711-74-0MW526.38FormulaC24H24BrN5O4
- CAS number
- 2921711-74-0
- Molecular weight
- 526.38
- Formula
- C24H24BrN5O4
- Solubility
- DMSO : 100 mg/mL (189·98 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
- InChIKey
- BPLNOSFMIIASSJ-UXHICEINSA-N
- Catalogue number
- GC71089
- Brand
- GLPBIO
Computed properties PubChem CID 156774920 · XLogP 4.7 · TPSA 129 Ų · H-bond donors 3
- XLogP
- 4.7
- TPSA
- 129 Ų
- H-bond donors
- 3
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 34
SMILES CNC(=O)C1=C(C(=CC(=C1)Br)[N+](=O)[O-])N[C@@H]2CCCC[C@@H]2NC(=O)C3=CN=CC4=CC=CC=C43
Computed descriptors from PubChem (CID 156774920), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il